Anti-vascular endothelial growth factor
Showing 26 - 50 of >10,000
Neovascular Age-related Macular Degeneration(nAMD) Trial in Shanghai, Tianjin (HG202)
Not yet recruiting
- Neovascular Age-related Macular Degeneration(nAMD)
- HG202
-
Shanghai, Shanghai, China
- +1 more
Sep 4, 2023
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +5 more
- Bevacizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 13, 2022
Refractory Angina Pectoris, Gene Transfer, Coronary Artery Disease Trial in Copenhagen, Kuopio (AdvVEGF-D, Control Rx)
Recruiting
- Refractory Angina Pectoris
- +2 more
- AdvVEGF-D
- Control Rx
-
Copenhagen, Denmark
- +1 more
Oct 19, 2022
Iris Trial in Assiut (Immunohistochemistry analysis)
Not yet recruiting
- Iris
- Immunohistochemistry analysis
-
Assiut, EgyptHassan Lotfy
Jul 29, 2022
Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell
Recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +9 more
- Bevacizumab
- Brigatinib
-
Duarte, California
- +4 more
Aug 17, 2022
Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8 Trial in Columbus
Recruiting
- Metastatic Colorectal Carcinoma
- +4 more
- Bevacizumab
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 14, 2021
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Not yet recruiting
- Metastatic Colon Adenocarcinoma
- +6 more
- Balstilimab
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 17, 2022
Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Non-Small Cell Cancer AJCC v7
Active, not recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Bevacizumab
- +2 more
-
Los Angeles, California
- +17 more
Jan 27, 2023
Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (biological, drug, other)
Active, not recruiting
- Invasive Breast Carcinoma
- Triple-Negative Breast Carcinoma
- Bevacizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 18, 2022
Diarrhea, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Duarte (other, dietary supplement, drug)
Active, not recruiting
- Diarrhea
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 7, 2022
Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,
Not yet recruiting
- Metastatic Colorectal Carcinoma
- +3 more
- Bevacizumab
- +11 more
- (no location specified)
May 9, 2023
Diabetic Macular Edema, Cataract Trial in Shanghai (Lucentis)
Unknown status
- Diabetic Macular Edema
- Cataract
-
Shanghai, Shanghai, ChinaChanghai Hospital
Mar 25, 2020
Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)
Active, not recruiting
- Advanced Malignant Neoplasm
- +38 more
- Bevacizumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,
Recruiting
- Cervical Adenocarcinoma
- +47 more
- Bevacizumab
- +3 more
-
Phoenix, Arizona
- +3 more
Dec 5, 2022
Uveitis, Macular Edema, Vascular Endothelial Growth Factor Trial in Beijing (intravitreal injection of Conbercept)
Terminated
- Uveitis
- +3 more
- intravitreal injection of Conbercept
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital (PUMCH)
Oct 24, 2022
Age Related Macular Degeneration Trial in China (HLX04-O,recombinant anti-vascular endothelial growth factor (VEGF) humanized
Recruiting
- Age Related Macular Degeneration
- HLX04-O,recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection
- Lucentis
-
Bengbu, Anhui, China
- +40 more
Apr 27, 2022
Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Stage III Liver Cancer, Stage IV Liver Cancer Trial in United States
Recruiting
- Combined Hepatocellular Carcinoma and Cholangiocarcinoma
- +2 more
- Atezolizumab
- +6 more
-
Auburn, California
- +16 more
Aug 17, 2022
Effect of Plasma Rich in Growth Factors on Semen Quality
Completed
- Vascular Endothelial Growth Factor Overexpression
- PRGF in candidates for sperm donors
-
Leioa, Vizcaya, Spain
- +2 more
Jul 29, 2022
Diabetic Macular Edema, Macular Ischemia, Diabetic Retinopathy Trial in Cairo (Intravitreal ranibizumab, Intravitreal
Recruiting
- Diabetic Macular Edema
- +3 more
- Intravitreal ranibizumab
- Intravitreal bevacizumab
-
Cairo, EgyptCairo University
Nov 26, 2021
Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage
Recruiting
- Advanced Solid Tumor
- Refractory Tumor
- Radiotherapy
- +4 more
-
Suzhou, ChinaThe Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023
Evaluation of New Biomarkers in Stage 3 and 4 Endometriosis
Completed
- Endometriosis
- endometriosis surgery
- other benign condition surgeries
-
Istanbul, Bagcilar, TurkeyBagcilar Teaching and Research Hospital
Mar 26, 2022
Peritoneal Malignant Mesothelioma Trial in United States (biological, drug, procedure)
Recruiting
- Peritoneal Malignant Mesothelioma
- Atezolizumab
- +8 more
-
Phoenix, Arizona
- +25 more
Feb 2, 2023
Low Vision, Neovascular Age-related Macular Degeneration Trial in Baltimore (Vision rehabilitation)
Completed
- Low Vision
- Neovascular Age-related Macular Degeneration
- Vision rehabilitation
-
Baltimore, MarylandWilmer Eye Institute
Dec 13, 2019
Metastatic Colorectal Carcinoma, Recurrent Colorectal Carcinoma, Refractory Colorectal Carcinoma Trial in United States (drug,
Active, not recruiting
- Metastatic Colorectal Carcinoma
- +5 more
- Atezolizumab
- +4 more
-
Phoenix, Arizona
- +9 more
Jan 5, 2022
Analgesia Methods on Vascular Endothelial Growth Factor* and
Completed
- Breast Cancer
- Morphine
- +2 more
-
Ankara, TurkeyDr.Abdurrahman Yurtaslan Ankara Oncology Train and Research Hosp
Oct 21, 2021